GovChime
Notice ID: cc93cf8ed0774bebbc781e5999c79061Solicitation

Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program

Responses closed . Full description on SAM.gov.

Overview

Response deadline
12:00 PM CDT
Posted
May 7, 2026
Notice type
Solicitation
Agency
Department of WarDEFENSE HEALTH AGENCY (DHA)

Notice details

Office
DEFENSE HEALTH AGENCY (DHA)
Place of performance
San Antonio, Texas, 78230
Last updated
Oct 28, 2026
First published
Last updated on SAM.gov

Identifiers

Solicitation number
HT9402-26-Q-9302
Notice ID
cc93cf8ed0774bebbc781e5999c79061

Description

The Department of War (DoW) is required by law (10 U.S.C. § 1074g) to establish an effective, efficient, integrated pharmacy benefits program for the Military Health System (MHS) which includes the purchase pharmaceutical agents. The law and implementing regulation (32 CFR Section 199.21) describe the process by which the DoW Pharmacy and Therapeutics (P&T) Committee will consider the relative clinical effectiveness and relative cost effectiveness of pharmaceutical agents in a therapeutic class in recommending the selection of agents for the DoW Uniform Formulary (UF) and, for cost sharing purposes, the classification of a pharmaceutical agent as generic, formulary, Basic Core Formulary (BCF), Extended Core Formulary (ECF), or non-formulary (NF). Prior to the scheduled P&T Committee meeting, a Request for Quotation (RFQ) for pharmaceutical agents within Drug Classes identified for placement on the UF has been issued to obtain quotes from industry. The Defense Health Agency may award Uniform Formulary Blanket Purchase Agreements (UF BPA) and the Uniform Formulary Additional Discount Program Agreements (UF ADP) based on the UF decision. This process is described in the attached RFQ.

P&T COMMITTEE MEETING: The following May 2026 newly approved drugs will be reviewed:

a.  Lifyorli - Oncological Agents - Glucocorticoid Receptor Antagonist

b. Quiofic - VITAMINS - WATER SOLUBLE

c. Widaplik - ANTIHYPERTENSIVE AGENTS – N/A

d. Saphnelo – IMMUNOSUPPRESSIVES – N/A
 

The RFQ, including UF BPA and UF ADP appendices are attached here in. The instructions, important deadlines, and points of contact are in document, RFQ HT9402-26-Q-9302.

Pre-quotation teleconference is on May 13, 2026. Details are stated in Part 2.4. Pre-Quotation Teleconference. Responses to the clinical questions in Part 3.4 shall be submitted via e-mail to the RFQ POC in Part 2.3.1., no later than the date stated in Part 2.3.2.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Secondary Contact

Documents

Files (9)

  • Amendment 1 HT9402-26-Q-9302 . A0001.pdf

    139 KBAdded in Solicitation version 2Posted
    Download
  • A-3 RFQ HT9402-26-Q-9302 . A0001.pdf

    793 KBAdded in Solicitation version 2Posted
    Download
  • A-3 RFQ HT9402-26-Q-9302.pdf

    793 KBAdded in Solicitation version 1Posted
    Download
  • A-3 Price List - Widaplik - Antihypertensive Agents-NA.xlsx

    45 KBAdded in Solicitation version 1Posted
    Download
  • A-3 Price List - Lifyorli - Oncological Agents - Glucocorticoid Receptor Antagonist.xlsx

    45 KBAdded in Solicitation version 1Posted
    Download
  • A-3 Price List - Saphnelo - Immunosuppressives - NA.xlsx

    45 KBAdded in Solicitation version 1Posted
    Download
  • A-3 Price List - Quiofic - Vitamins - Water Soluble.xlsx

    44 KBAdded in Solicitation version 1Posted
    Download
  • A-3 Price Appendix FAQ NAD.pdf

    231 KBAdded in Solicitation version 1Posted
    Download
  • A-3 DoD Formulary Placement of FDA Newly Approved Drugs.pdf

    83 KBAdded in Solicitation version 1Posted
    Download

Lifecycle

  1. 1
    Version 1Solicitation

    Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program

    Notice fdb09bd311224930bd4679692488acb0 on SAM.gov

  2. 2
    Version 2SolicitationCurrent

    Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program

    Notice cc93cf8ed0774bebbc781e5999c79061 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

HT9402-26-Q-9302

Archive Date

Nov 28, 2026

Office Address

JBSA FT SAM HOUSTON, TX, 78234